Vascular Biogenics Net Tangible Assets

Vascular Biogenics (VBLT) currently reports a net tangible assets of $0 as of June 2024. That compares with $19M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Vascular Biogenics's net tangible assets history and peer comparisons.

Vascular Biogenics's net tangible assets decreased from $19M to $0 — a 100.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vascular Biogenics reported $0 in net tangible assets as of June 2024. That compares with $19M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vascular Biogenics, and consider following VBLT for alerts when major investors trade the stock.

Vascular Biogenics is classified in the Healthcare sector. On net tangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VBLT with unrelated industries.